By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Acura Pharmaceuticals, Inc. 

616 N. North Court
Suite 120
Palatine  Illinois  60067  U.S.A.
Phone: 847-705-7709 Fax: 847-705-5399



Company News
Acura Pharma (ACUR) Initiates Second Clinical Study On LTX-04 5/19/2017 7:57:18 AM
Acura Pharma (ACUR) Announces First Quarter 2017 Financial Results 5/15/2017 10:11:43 AM
Acura Pharma (ACUR) Announces Fourth Quarter 2016 And Full Year 2016 Financial Results 4/3/2017 2:12:23 PM
Acura Pharma (ACUR) And Mainpointe Pharmaceuticals Announce Deal For Nexafed® Productsa 3/17/2017 11:05:15 AM
Acura Pharma (ACUR) Common Stock To Trade On The OTCQB Market 2/16/2017 8:51:35 AM
Acura Pharma (ACUR) Exploring Strategic Alternatives, Including a Possible Sale 1/4/2017 5:43:00 AM
Purdue Pharma L.P. Announces Patent Agreement With Egalet And Acura Pharmaceuticals, Inc. (ACUR) 5/23/2016 6:19:58 AM
Acura Pharmaceuticals, Inc. (ACUR) Provides Development Update On Its LIMITX Abuse Deterrent Technology 2/2/2016 10:41:10 AM
Acura Pharmaceuticals, Inc. (ACUR) Earns Accolades From Frost & Sullivan For Developing A Novel Technology Platform To Prevent The Abuse Of Opioid-Based Medication Through Oral Administration 11/9/2015 11:18:10 AM
Acura Pharmaceuticals, Inc. (ACUR) Hydrocodone Bitartrate With Acetaminophen Tablets Meet Clinical Endpoints 9/29/2014 12:24:36 PM